| Literature DB >> 16918512 |
J Bousquet1, P van Cauwenberge, N Aït Khaled, C Bachert, C E Baena-Cagnani, J Bouchard, C Bunnag, G W Canonica, K-H Carlsen, Y-Z Chen, A A Cruz, A Custovic, P Demoly, R Dubakiene, S Durham, W Fokkens, P Howarth, J Kemp, M L Kowalski, V Kvedariene, B Lipworth, R Lockey, V Lund, S Mavale-Manuel, E O Meltzer, J Mullol, R Naclerio, K Nekam, K Ohta, N Papadopoulos, G Passalacqua, R Pawankar, T Popov, P Potter, D Price, G Scadding, F E R Simons, V Spicak, E Valovirta, D-Y Wang, B Yawn, O Yusuf.
Abstract
The pharmacologic treatment of allergic rhinitis proposed by ARIA is an evidence-based and step-wise approach based on the classification of the symptoms. The ARIA workshop, held in December 1999, published a report in 2001 and new information has subsequently been published. The initial ARIA document lacked some important information on several issues. This document updates the ARIA sections on the pharmacologic and anti-IgE treatments of allergic rhinitis. Literature published between January 2000 and December 2004 has been included. Only a few studies assessing nasal and non-nasal symptoms are presented as these will be discussed in a separate document.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16918512 DOI： 10.1111/j.1398-9995.2006.01144.x
Source DB: PubMed Journal: Allergy ISSN： 0105-4538 Impact factor: 13.146